company background image
AUGX logo

Augmedix NasdaqCM:AUGX Stock Report

Last Price

US$0.91

Market Cap

US$43.8m

7D

-9.2%

1Y

-80.4%

Updated

11 Jul, 2024

Data

Company Financials +

Augmedix, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Augmedix
Historical stock prices
Current Share PriceUS$0.91
52 Week HighUS$6.25
52 Week LowUS$0.73
Beta-0.22
11 Month Change5.59%
3 Month Change-76.17%
1 Year Change-80.39%
33 Year Change-83.18%
5 Year Changen/a
Change since IPO-81.84%

Recent News & Updates

Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jun 19
Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?

May 21
Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?

Recent updates

Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jun 19
Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?

May 21
Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?

Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless

Apr 25
Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless

Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward

Mar 24

Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 09
Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Augmedix reports Q2 results

Aug 08

Augmedix: A Splendid Long-Term Investing Opportunity

Jan 21

Shareholder Returns

AUGXUS Healthcare ServicesUS Market
7D-9.2%2.7%1.0%
1Y-80.4%-23.7%21.7%

Return vs Industry: AUGX underperformed the US Healthcare Services industry which returned -25.5% over the past year.

Return vs Market: AUGX underperformed the US Market which returned 22.8% over the past year.

Price Volatility

Is AUGX's price volatile compared to industry and market?
AUGX volatility
AUGX Average Weekly Movement17.0%
Healthcare Services Industry Average Movement7.8%
Market Average Movement5.8%
10% most volatile stocks in US Market14.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: AUGX's share price has been volatile over the past 3 months.

Volatility Over Time: AUGX's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20131,430Manny Krakariswww.augmedix.com

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones.

Augmedix, Inc. Fundamentals Summary

How do Augmedix's earnings and revenue compare to its market cap?
AUGX fundamental statistics
Market capUS$43.80m
Earnings (TTM)-US$20.43m
Revenue (TTM)US$48.70m

0.9x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AUGX income statement (TTM)
RevenueUS$48.70m
Cost of RevenueUS$25.22m
Gross ProfitUS$23.48m
Other ExpensesUS$43.91m
Earnings-US$20.43m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.42
Gross Margin48.22%
Net Profit Margin-41.95%
Debt/Equity Ratio115.0%

How did AUGX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.